Fulgent Genetics (FLGT) Research & Development (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Research & Development for 11 consecutive years, with $14.2 million as the latest value for Q4 2025.
- Quarterly Research & Development rose 16.98% to $14.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.9 million through Dec 2025, up 10.42% year-over-year, with the annual reading at $53.9 million for FY2025, 10.42% up from the prior year.
- Research & Development hit $14.2 million in Q4 2025 for Fulgent Genetics, up from $13.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $14.2 million in Q4 2025 to a low of $5.3 million in Q2 2021.
- Historically, Research & Development has averaged $9.9 million across 5 years, with a median of $9.9 million in 2023.
- Biggest five-year swings in Research & Development: soared 187.29% in 2021 and later dropped 0.04% in 2025.
- Year by year, Research & Development stood at $7.5 million in 2021, then rose by 14.0% to $8.5 million in 2022, then surged by 40.46% to $12.0 million in 2023, then increased by 1.35% to $12.1 million in 2024, then increased by 16.98% to $14.2 million in 2025.
- Business Quant data shows Research & Development for FLGT at $14.2 million in Q4 2025, $13.9 million in Q3 2025, and $13.5 million in Q2 2025.